Culture conditions modulate cell phenotype and cause selection of subpopulations in PC3 prostate cancer cell lineFESTUCCIA, Claudio; GRAVINA, Giovanni Luca; ANGELUCCI, Adriano et al.Anticancer research. 2000, Vol 20, Num 6B, pp 4367-4371, issn 0250-7005Article

Prostate cancer cell proliferation is strongly reduced by the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in vitro on human cell lines and primary culturesVICENTINI, Carlo; FESTUCCIA, Claudio; GRAVINA, Giovanni Luca et al.Journal of cancer research and clinical oncology. 2003, Vol 129, Num 3, pp 165-174, issn 0171-5216, 10 p.Article

Epithelial and prostatic marker expression in short-term primary cultures of human prostate tissue samplesFESTUCCIA, Claudio; ANGELUCCI, Adriano; GRAVINA, Giovanni Luca et al.International journal of oncology. 2005, Vol 26, Num 5, pp 1353-1362, issn 1019-6439, 10 p.Article

Osteopontin enhances the cell proliferation induced by the epidermal growth factor in human prostate cancer cellsANGELUCCI, Adriano; FESTUCCIA, Claudio; GRAVINA, Giovanni Luca et al.The Prostate. 2004, Vol 59, Num 2, pp 157-166, issn 0270-4137, 10 p.Article

Antitumor Effects of Carnertinib in Castration Resistant Prostate Cancer Models: A Comparative Study With ErlotinibGRAVINA, Giovanni Luca; MARAMPON, Francesco; PICCOLELLA, Margherita et al.The Prostate. 2011, Vol 71, Num 14, pp 1481-1491, issn 0270-4137, 11 p.Article

In vitro and invivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinomaFESTUCCIA, Claudio; GRAVINA, Giovanni Luca; MUZI, Paola et al.The Prostate. 2007, Vol 67, Num 12, pp 1255-1264, issn 0270-4137, 10 p.Article

Long-term presence of androgens and anti-androgens modulate EGF-receptor expression and MAP-kinase phosphorylation in androgen receptor-prostate positive cancer cellsGRAVINA, Giovanni Luca; FESTUCCIA, Claudio; ANGELUCCI, Adriano et al.International journal of oncology. 2004, Vol 25, Num 1, pp 97-104, issn 1019-6439, 8 p.Article

Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitroFESTUCCIA, Claudio; MUZI, Paola; GRAVINA, Giovanni Luca et al.International journal of oncology. 2006, Vol 30, Num 1, pp 193-200, issn 1019-6439, 8 p.Article

Uncoupling of the epidermal growth factor receptor from downstream signal transduction molecules guides the acquired resistance to gefitinib in prostate cancer cellsFESTUCCIA, Claudio; GRAVINA, Giovanni Luca; MILLIMAGGI, Danilo et al.Oncology reports. 2007, Vol 18, Num 2, pp 503-511, issn 1021-335X, 9 p.Article

Additive antitumor effects of the epidermal growth factor receptor tyrosine kinase inhibitor, gefitinib (Iressa), and the nonsteroidal antiandrogen, bicalutamide (Casodex), in prostate cancer cells in vitroFESTUCCIA, Claudio; GRAVINA, Giovanni Luca; ANGELUCCI, Adriano et al.International journal of cancer. 2005, Vol 115, Num 4, pp 630-640, issn 0020-7136, 11 p.Article

Evaluation of metastatic potential in prostate carcinoma: An in vivo modelANGELUCCI, Adriano; GRAVINA, Giovanni Luca; RUCCI, Nadia et al.International journal of oncology. 2004, Vol 25, Num 6, pp 1713-1720, issn 1019-6439, 8 p.Article

Ozarelix, a Fourth Generation GnRH Antagonist, Induces Apoptosis in Hormone Refractory Androgen Receptor Negative Prostate Cancer Cells Modulating Expression and Activity of Death ReceptorsFESTUCCIA, Claudio; DONDI, Donatella; PICCOLELLA, Margherita et al.The Prostate. 2010, Vol 70, Num 12, pp 1340-1349, issn 0270-4137, 10 p.Article

Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity : EGF-receptor inhibition may prevent tumor cell disseminationFESTUCCIA, Claudio; ANGELUCCI, Adriano; GRAVINA, Giovanni Luca et al.Thrombosis and haemostasis. 2005, Vol 93, Num 5, pp 964-975, issn 0340-6245, 12 p.Article

Premature Ejaculation Results in Female Sexual Distress: Standardization and Validation of a New Diagnostic Tool for Sexual DistressLIMONCIN, Erika; TOMASSETTI, Marco; JANNINI, Emmanuele A et al.The Journal of urology. 2013, Vol 189, Num 5, pp 1830-1835, issn 0022-5347, 6 p.Article

Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer ModelsGRAVINA, Giovanni Luca; MARAMPON, Francesco; JANNINI, Emmanuele A et al.Endocrinology (Philadelphia). 2011, Vol 152, Num 12, pp 4550-4561, issn 0013-7227, 12 p.Article

5-Azacitidine Restores and Amplifies the Bicalutamide Response on Preclinical Models of Androgen Receptor Expressing or Deficient ProstateTumorsGRAVINA, Giovanni Luca; MARAMPON, Francesco; DI STASO, Mario et al.The Prostate. 2010, Vol 70, Num 11, pp 1166-1178, issn 0270-4137, 13 p.Article

Detection of telomerase activity in prostate massage samples improves differentiating prostate cancer from benign prostatic hyperplasiaVICENTINI, Carlo; GRAVINA, Giovanni Luca; BOLOGNA, Mauro et al.Journal of cancer research and clinical oncology. 2004, Vol 130, Num 4, pp 217-221, issn 0171-5216, 5 p.Article

Bicalutamide dose-dependently inhibits proliferation in Human prostatic carcinoma cell lines and primary culturesVICENTINI, Carlo; FESTUCCIA, Claudio; ANGELUCCI, Adriano et al.Anticancer research. 2002, Vol 22, Num 5, pp 2917-2922, issn 0250-7005, 6 p.Article